Immunohistochemical study of 65-kDa oncofetal protein expression in breast cancer

Breast

Volumn 6, Issue 5, 1997, Pages 284-290

  Mirowski, M ^a,b   Blonski, J Z ^b   Niewiadomska, H ^b   Olborski, B ^b   Walaszek, Z ^c   Hanausek, M ^c   Wozniak, L ^b  

^a Department of Biochemistry   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; ONCOFETAL ANTIGEN; PHOSPHOPROTEIN; POLYCLONAL ANTIBODY; SYNAPTOTAGMIN; TUMOR ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030808839     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90006-0     Document Type: Article

References (33)

1. Mirowski M, Sherman U, Hanausek M. Purification and characterization of a 65-kDa tumor-associated phosphoprotein from rat transplantable hepatocellular carcinoma 1682 cell line. Prot Expr Pur 1992; 3: 196-203.
2. Mirowski M, Walaszek Z, Sherman U, Hanausek M. Comparative structural analysis of human and rat 65 kDa tumor-associated phosphoproteins. Int J Biochem 1993; 25: 1865-1871.
3. Hanausek-Walaszek M, Adams A, Sherman U. Expression of a 65-kDa tumor-associated protein and persistence of altered hepatic foci. Prog Clin Biol Res 1991; 369: 91-103.
4. Mirowski M, Hanausek M, Sherman U, Adams A K, Walaszek Z, Slaga T J. An enzyme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new tumor marker for cancer risk assessment in rodents and humans. Prog Clin Biol Res 1992; 374: 281-294.
5. Hanausek-Walaszek M, Del-Rio M, Adams A K. Immunochemical demonstration of mRNA-transport protein in rat liver putative preneoplastic foci. Cancer Lett 1989; 48: 213-221.
6. Wang S, Mirowski M, Sherman U, Walaszek Z, Hanausek M. Monoclonal antibodies against a 65-kDa tumor-associated protein: development and use in cancer detection. Hybridoma 1993; 12: 167-176.
7. Mirowski M, Klijanienko J, Wang S, Vielh P, Walaszek Z, Hanausek M. Serological and immunohistochemical detection of a 65 kDa oncofetal protein in breast cancer. Eur J Cancer 1994; 30A: 1108-1113.
8. Bloom H J, Richardson W W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed 15 years. Br J Cancer 1957; 11: 357-337.
9. Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
10. Ausubel F M, Brent R, Kingston R E et al. Current Protocol in Molecular Biology. Wiley & Sons, Inc. 1989.
11. Fernandez-Patron C, Castellanos-Serra L, Rodriguez P. Reverse staining of sodium dodecyl sulfate polyacrylamide gels by imidazole-zinc salts: sensitive detection of unmodified proteins. Bio Techniques 1992; 12: 564-573.
12. Elder J H, Piskett R A, Hampton J, Lerner R A. Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent system using microgram quantities of total protein. J Biol Chem 1977; 252: 6510-6515.
13. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114-123.
14. Towbin H, Staehelin T, Gordon J. Electrophoretic tranfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
15. Urban J L, Schreiber H. Tumor antigens. Ann Rev Immunol 1992; 10: 617-644.
16. Boxer G M, Abassi A M, Pedley R B, Begent R H J. Location of monoclonal antibodies reacting with epitopes on carcinoembryonic antigen (CEA) - implication for target therapy. Br J Cancer 1994; 69: 307-314.
17. Chambost H, Brasseur F, Coulie P et al. A tumor-associated antigen expression in human haematological malignancies. Br J Haematol 1993; 84: 524-526,
18. VanDerBruggen P, Traversari C et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on human melanoma. Science 1991; 254: 1643-1647.
19. Lim S H, Marcus R E. Monoclonal antibody (MoAb) therapy in Hodgkin's lymphomas. Blood Rev 1992; 6: 157-162.
20. Scheinberg D A, Lovett D, Divgi C R. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol 1991; 9: 478-490.
21. Brown S, Miller R A, Borning S J. Treatment of B-cell lymphomas with antiidiotype antibodies alone and in combination with alpha-interferon. Blood 1989; 73: 651-661.
22. Chigira M, Arita S, Watanabe H. Myth of tumor immunology (review). Int J Oncol 1993; 3: 645-654.
23. Waldman T A. Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune disease and for the prevention of allograft rejection. Annu Rev Immunol 1992; 10: 675-704.
24. Nicholson S, Richard J, Sinsbury C et al. Epidermal growth factor receptor (EGFr): results of a 6 year follow-up study in operable breast cancer with emphasis on the node-negative subgroup. Br J Cancer 1991; 63: 146-150.
25. Aziz D C . Quantitation of estrogen and progesterone receptors by immunocytochemical and image analysis. Am J Clin Pathol 1992; 98: 105-111.
26. Germa R J, Llanos M, Tabernero J M, Mora J. False elevation of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer 1993; 72: 2491-2494.
27. Bates S E. Clinical applications of serum tumor markers. Ann Intern Med 1991; 115: 623.
28. Fletcher R H. Carcinoembryonic antigen. Ann Intern Med 1986; 104: 66.
29. Bates S E. The use of potential of serum tumor markers, new and old. Drugs 1989; 38: 9-18.
30. Horan Hand P, Nuti M, Cochler D, Schlom J. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell population using monoclonal antibodies to tumor-associated antigens. Cancer Res 1983; 43: 728-735.
31. Contegiacomo A, Alimandi M, Muraro R et al. Expression of epitopes of the tumor-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur J Cancer 1994; 30A: 813-820.
32. Stempien M. P65 protein in infiltrating ductal breast cancer in women. PhD Thesis. Medical University, Lodz, Poland, 1996 (in Polish).
33. Bilimoria M M, Morrow M. The women at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin 1995; 30A: 1957-1961.